GST Show Cause Notice from Mysore Tax Authority for FY 2022-23
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts more than Nifty Smallcap 250 and 2.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jubilant Pharmova received a GST Show Cause Notice from the Assistant Commissioner of Commercial Taxes, Mysore for FY 2022-23. The notice alleges ineligible ITC, excess ITC availed, and differential tax liability based on E-waybill records. Total demand: Tax Rs 33.58 Cr plus Interest Rs 20.15 Cr plus Penalty Rs 33.58 Cr, totalling Rs 87.31 Cr. The company calls the notice factually and legally incorrect and plans to file a detailed reply. It expects no financial or operational impact.
A contested GST demand of Rs 87.31 Cr; company expects no material impact as it plans to contest with a strong case.